BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 24706819)

  • 1. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.
    Muschamp JW; Hollander JA; Thompson JL; Voren G; Hassinger LC; Onvani S; Kamenecka TM; Borgland SL; Kenny PJ; Carlezon WA
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1648-55. PubMed ID: 24706819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin/hypocretin role in reward: implications for opioid and other addictions.
    Baimel C; Bartlett SE; Chiou LC; Lawrence AJ; Muschamp JW; Patkar O; Tung LW; Borgland SL
    Br J Pharmacol; 2015 Jan; 172(2):334-48. PubMed ID: 24641197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours.
    Thomas CS; Mohammadkhani A; Rana M; Qiao M; Baimel C; Borgland SL
    Neuropsychopharmacology; 2022 Feb; 47(3):728-740. PubMed ID: 34663867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing roles of cotransmission of dynorphin and hypocretin on reward and motivation.
    Li X; Marchant NJ; Shaham Y
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5765-6. PubMed ID: 24706899
    [No Abstract]   [Full Text] [Related]  

  • 5. Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons.
    Baimel C; Lau BK; Qiao M; Borgland SL
    Cell Rep; 2017 Feb; 18(6):1346-1355. PubMed ID: 28178514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction.
    Aston-Jones G; Smith RJ; Sartor GC; Moorman DE; Massi L; Tahsili-Fahadan P; Richardson KA
    Brain Res; 2010 Feb; 1314():74-90. PubMed ID: 19815001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress induces reinstatement of extinguished cocaine conditioned place preference by a sequential signaling via neuropeptide S, orexin, and endocannabinoid.
    Chou YH; Hor CC; Lee MT; Lee HJ; Guerrini R; Calo G; Chiou LC
    Addict Biol; 2021 May; 26(3):e12971. PubMed ID: 33078457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network.
    Wang B; You ZB; Wise RA
    Biol Psychiatry; 2009 May; 65(10):857-62. PubMed ID: 19251246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference.
    Richardson KA; Aston-Jones G
    J Neurosci; 2012 Mar; 32(11):3809-17. PubMed ID: 22423101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic regulation of lateral hypothalamic glucose-inhibited orexin neurons may influence midbrain reward neurocircuitry.
    Sheng Z; Santiago AM; Thomas MP; Routh VH
    Mol Cell Neurosci; 2014 Sep; 62():30-41. PubMed ID: 25107627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons.
    Borgland SL; Storm E; Bonci A
    Eur J Neurosci; 2008 Oct; 28(8):1545-56. PubMed ID: 18793323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lateral hypothalamic orexin neurons in reward processing and addiction.
    Aston-Jones G; Smith RJ; Moorman DE; Richardson KA
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):112-21. PubMed ID: 18655797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides.
    Li Y; van den Pol AN
    J Neurosci; 2006 Dec; 26(50):13037-47. PubMed ID: 17167093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cocaine place conditioning, chronic escalating-dose "binge" pattern cocaine administration and acute withdrawal on orexin/hypocretin and preprodynorphin gene expressions in lateral hypothalamus of Fischer and Sprague-Dawley rats.
    Zhou Y; Cui CL; Schlussman SD; Choi JC; Ho A; Han JS; Kreek MJ
    Neuroscience; 2008 Jun; 153(4):1225-34. PubMed ID: 18436386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
    Mahler SV; Smith RJ; Aston-Jones G
    Psychopharmacology (Berl); 2013 Apr; 226(4):687-98. PubMed ID: 22411428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons.
    Tung LW; Lu GL; Lee YH; Yu L; Lee HJ; Leishman E; Bradshaw H; Hwang LL; Hung MS; Mackie K; Zimmer A; Chiou LC
    Nat Commun; 2016 Jul; 7():12199. PubMed ID: 27448020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of orexin-2 receptors in the ventral tegmental area and nucleus accumbens in the antinociception induced by the lateral hypothalamus stimulation in rats.
    Azhdari-Zarmehri H; Reisi Z; Vaziri A; Haghparast A; Shaigani P; Haghparast A
    Peptides; 2013 Sep; 47():94-8. PubMed ID: 23891649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration.
    EspaƱa RA; Melchior JR; Roberts DC; Jones SR
    Psychopharmacology (Berl); 2011 Mar; 214(2):415-26. PubMed ID: 20959967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain site-specific regulation of hedonic intake by orexin and DYN peptides: role of the PVN and obesity.
    Mattar P; Uribe-Cerda S; Pezoa C; Guarnieri T; Kotz CM; Teske JA; Morselli E; Perez-Leighton C
    Nutr Neurosci; 2022 May; 25(5):1105-1114. PubMed ID: 33151127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine.
    Zarepour L; Fatahi Z; Sarihi A; Haghparast A
    Neuropeptides; 2014 Jun; 48(3):179-85. PubMed ID: 24793540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.